Solid Biosciences Inc. (SLDB)
NASDAQ: SLDBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 6.85 0.00%
SLDB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $734.49M
- EPS (TTM)
- -$1.89
- Dividend yield
- None
- 52-week range
- 3.79 – 11.45
- Day range
- 6.69 – 6.98
- Volume / Avg
- 744.61K / 1.10M
- Beta
- —
- Shares outstanding
- 107.23M
- Next earnings
- Nov 2, 2026
52-week range
SLDB stock today
Solid Biosciences (SLDB) closed at $6.85 on Oct 7, down 1.01% (-$0.07), versus the S&P 500's 0.22% decline. Shares are 40.2% below their 52-week high of $11.45, set on Jul 6, 2026 and 80.7% above the 52-week low of $3.79, in the middle of the past year's range. SLDB is up 21.5% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 24.1%.
Solid Biosciences has posted a net loss over the last twelve months (EPS of -$1.89), so its P/E ratio is not meaningful. Solid Biosciences's next earnings report is expected on Nov 2, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Solid Biosciences
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- Charlestown, MA
- IPO year
- 2018
Earnings
Earnings history- Next report
- Nov 2, 2026
- EPS estimate
- $-0.37
Solid Biosciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ATTOAttovia Therapeutics Inc. | 16.42 | -6.17% | $749.59M | vs SLDB |
| CADLCandel Therapeutics Inc. | 9.82 | -0.51% | $751.41M | vs SLDB |
| DNAGinkgo Bioworks Holdings Inc. Class A | 11.47 | -7.57% | $772.39M | vs SLDB |
| PRMEPrime Medicine Inc. | 3.90 | +11.43% | $707.37M | vs SLDB |
| FDMT4D Molecular Therapeutics Inc. | 12.59 | +0.24% | $695.52M | vs SLDB |
| AURAAura Biosciences Inc. | 6.46 | +4.70% | $669.93M | vs SLDB |
| SANASana Biotechnology Inc. | 2.72 | -1.09% | $814.26M | vs SLDB |
| SLBTSL Science Holding Limited | 1.51 | -0.66% | $846.75M | vs SLDB |
Indexes, lists and sector
Largest Health Care stocks
Solid Biosciences stock FAQ
What is Solid Biosciences's stock price today?
SLDB last traded at $6.85 as of Oct 7, 4:00 PM EDT, down 1.01% on the day. Prices are delayed at least 15 minutes.
Does Solid Biosciences pay a dividend?
No. Solid Biosciences does not currently pay a regular cash dividend.
When is Solid Biosciences's next earnings date?
Solid Biosciences is expected to report earnings on Monday, November 2, 2026. Analysts expect EPS of $-0.37.
Has SLDB ever split its stock?
Yes. The most recent SLDB stock split was a 1-for-15 split on Oct 28, 2022.
What is the SLDB 52-week high?
The 52-week high for SLDB is $11.45 and the 52-week low is $3.79. The stock is currently 40.2% below its high.